Research, Select, & Monitor Monday, March 25, 2019 12:09:42 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Natures Sunshine Products Inc.$9.14$.03.33%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Natures Sunshine Products Inc. vs Drug Related Products

Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.

Health and nutritional products are not the only items these companies produce. Many of them have their hand in the over the counter medicinal market as well. Some companies here will contract their product out to be used as store branded materials. As far as over the counter drugs are concerned, many pain relievers, feminine hygiene, and skin care products come from the companies listed below. Moving away from actual drugs and to more everyday type items, there is also a firm here that makes things like anti-perspirants, deodorants, laxatives, condoms, and pet care products.
 Totals Company Industry
  Sales: $364.8 Mil $6,949.9 Mil
  Market Cap: $174.9 Mil $14,540.6 Mil
  Analysts Recommendation: N/A Buy

 Averages Company Industry
  Historic Revenue: 6.7% 11.0%
  Estimated Revenue: N/A N/A
  Historic Earnings: N/A (20.6%)
  Estimated Earnings: N/A 1.5%
  Stock Price (1 Year): (17.9%) (9.3%)
  Cash per Share: 16.2% (5.5%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 24.2
  Price-to-Sales: .5 N/A
  Price-to-Book: 1.5 2.8
  Dividend Yield: N/A N/A
  Market Cap: $174.9 Mil $2,077.2 Mil
  Net Margin: (.2%) 5.3%
  Gross Margin: 73.8% 57.6%
  Return on Equity: (.0) .1
  Return on Assets: (.0) .1
  Balance Sheet
  Current Ratio: 1.6 3.1
  Quick Ratio: 1.0 2.4
  Cash Ratio: .8 1.7
  Debt-to-Equity: .6 .6
  Interest Coverage: (4.5) 46.4
  Relative-Strength Index: N/A N/A

 Other companies in Drug Related Products Price Market Cap
  Perrigo Co.  (PRGO) $47.25 $6,419.4 Mil
  SPDR S\/T Muni Bd Barclays Capital  (SHM) $48.46 $3,835.6 Mil
  USANA Health Sciences Inc  (USNA) $86.20 $2,067.1 Mil
  Inogen, Inc.  (INGN) $90.12 $1,924.1 Mil
  Natural Alternatives Internati  (NAII) $10.96 $76.7 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.